Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffold.

Goher SS, Griffett K, Hegazy L, Elagawany M, Arief MMH, Avdagic A, Banerjee S, Burris TP, Elgendy B.

Bioorg Med Chem Lett. 2019 Feb 1;29(3):449-453. doi: 10.1016/j.bmcl.2018.12.025. Epub 2018 Dec 15.

PMID:
30587446
2.

Inhibition of Hepatotoxicity by a LXR Inverse Agonist in a Model of Alcoholic Liver Disease.

Sengupta M, Griffett K, Flaveny CA, Burris TP.

ACS Pharmacol Transl Sci. 2018 Sep 14;1(1):50-60. doi: 10.1021/acsptsci.8b00003. Epub 2018 Jul 25.

3.

Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease.

Griffett K, Burris TP.

Biochem Biophys Res Commun. 2016 Oct 21;479(3):424-428. doi: 10.1016/j.bbrc.2016.09.036. Epub 2016 Sep 25.

4.

Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis.

Flaveny CA, Griffett K, El-Gendy Bel-D, Kazantzis M, Sengupta M, Amelio AL, Chatterjee A, Walker J, Solt LA, Kamenecka TM, Burris TP.

Cancer Cell. 2015 Jul 13;28(1):42-56. doi: 10.1016/j.ccell.2015.05.007. Epub 2015 Jun 25.

5.

The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis.

Griffett K, Welch RD, Flaveny CA, Kolar GR, Neuschwander-Tetri BA, Burris TP.

Mol Metab. 2015 Feb 9;4(4):353-7. doi: 10.1016/j.molmet.2015.01.009. eCollection 2015 Apr.

6.

Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour.

Banerjee S, Wang Y, Solt LA, Griffett K, Kazantzis M, Amador A, El-Gendy BM, Huitron-Resendiz S, Roberts AJ, Shin Y, Kamenecka TM, Burris TP.

Nat Commun. 2014 Dec 23;5:5759. doi: 10.1038/ncomms6759.

7.

The mammalian clock and chronopharmacology.

Griffett K, Burris TP.

Bioorg Med Chem Lett. 2013 Apr 1;23(7):1929-34. doi: 10.1016/j.bmcl.2013.02.015. Epub 2013 Feb 13. Review.

8.

Nuclear receptors and their selective pharmacologic modulators.

Burris TP, Solt LA, Wang Y, Crumbley C, Banerjee S, Griffett K, Lundasen T, Hughes T, Kojetin DJ.

Pharmacol Rev. 2013 Mar 1;65(2):710-78. doi: 10.1124/pr.112.006833. Print 2013 Apr. Review.

PMID:
23457206
9.

A liver-selective LXR inverse agonist that suppresses hepatic steatosis.

Griffett K, Solt LA, El-Gendy Bel-D, Kamenecka TM, Burris TP.

ACS Chem Biol. 2013 Mar 15;8(3):559-67. doi: 10.1021/cb300541g. Epub 2012 Dec 27.

PMID:
23237488

Supplemental Content

Loading ...
Support Center